Target intelligence / Profile preview

Escherichia coli colonization factor antigen CS1 (CS1)

Target
CS1
Molecular classification
Fimbrial adhesin, Bacterial pilus (class 5b fimbriae), Adhesion molecule, Surface virulence factor
01

Overview

Escherichia coli colonization factor antigen CS1 is a proteinaceous, surface-expressed fimbria (pilus) found on the surface of enterotoxigenic Escherichia coli (ETEC), belonging to the class 5b group of fimbriae. The CS1 pilus consists of a helical stalk made up of the major pilin subunit CooA, which is structurally similar to the CFA/I fimbrial pilin CfaB. At the tip of the pilus is a minor adhesive subunit, CooD, which is essential for both pilus assembly and for ETEC adhesion to intestinal epithelial cells. This adhesion is a critical early event in ETEC infection, enabling colonization of the intestinal mucosa and subsequent diarrheal disease. Antibodies targeting the minor subunit CooD can block adhesion and may have potential in vaccines or therapeutic interventions. CS1 is closely related to other colonization factors such as CFA/I, CS4, CS14, generating a subclassification (class 5 fimbriae, specifically subclass 5b). Differences in sequence and surface structure can allow for antigenic variation, posing challenges for immune clearance and vaccine coverage.

Other names
Coli surface antigen 1CS1 pilusColonization factor antigen I-related fimbriae (subclass 5b)
02

Mechanism of action

Prevention of CS1-mediated ETEC adhesion to host cells, often through antibody-mediated blocking of the tip adhesin (CooD); Inhibition of hemagglutination (blocking binding to erythrocytes and epithelial cells)

03

Biological functions

Mediates adherence of enterotoxigenic Escherichia coli (ETEC) to intestinal epithelial cellsFacilitates colonization of the small intestinePlays a role in the early step of enteric infection
04

Disease associations

Infection (especially diarrheal disease caused by ETEC)Pathogen colonization of gut mucosa
05

Safety considerations

Antigenic diversity and potential for immune evasion through sequence variation in fimbrial proteinsSurfaces exposed on CS1 (as with other class 5 fimbriae) may undergo antigenic variation, which can limit cross-protective efficacy of vaccines or immunotherapies
06

Interacting drugs

No approved therapeutic drugs submitted specifically for CS1, but experimental strategies include anti-adhesion compounds and blocking antibodies

1 more in the full profile.

07

Biomarkers

Presence of CS1 fimbrial genes or proteins can serve as a molecular biomarker for identifying ETEC expressing this colonization factor

Beyond the preview

Go deeper on Escherichia coli colonization factor antigen CS1 (CS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Escherichia coli colonization factor antigen CS1 (CS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call